LIPOPROTEIN(A) AND PREVALENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Barkas, F. [1 ]
Koutsogianni, A. [1 ]
Adamidis, P. [1 ]
Anastasiou, G. [1 ]
Sakkou, S. -F. [1 ]
Kyrili, K. [1 ]
Liamis, G. [1 ]
Liberopoulos, E. [2 ]
机构：
[1] Univ Ioannina, Sch Hlth Sci, Dept Internal Med, Fac Med, Ioannnina, Greece
[2] Natl & Kapodistrian Univ Athens, Propaideut Dept Med 1, Sch Med, Athens, Greece
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP160
引用
收藏
页码：E136 / E137
页数：2
相关论文
共 50 条
  • [11] Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status
    Zhao, Yanglu
    Sung, Jennifer C.
    Browne, Auris
    Wong, Nathan D.
    DIABETES, 2020, 69
  • [12] Lipoprotein a levels and atherosclerotic cardiovascular disease in hemodialysis patients
    Garcia de la Vega, Cristina
    Blanco, Miguel A.
    Aguilar, Jose C.
    Hernandez, Teresa
    Grande, Carmen
    Quintanilla, Nuria
    Sanchez, Jose M.
    Cives, Alejandro
    Garcia-Bernalt, Vanesa
    Davin, Maria E.
    Rocha, Andre
    Deira, Javier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1453 - I1453
  • [13] Lipoprotein a levels and atherosclerotic cardiovascular disease in hemodialysis patients
    de la Vega, Cristina Garcia
    Blanco, Miguel A.
    Aguilar, Jose C.
    Hernandez, Teresa
    Grande, Carmen
    Quintanilla, Nuria
    Sanchez, Jose M.
    Cives, Alejandro
    Garcia-Bernalt, Vanesa
    Davin, Maria E.
    Rocha, Andre
    Deira, Javier
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [14] Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes (2017)
    Standl, E.
    Schnell, O.
    McGuire, K.
    Ceriello, A.
    Ryden, L.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : E3 - E3
  • [15] Construction of a Nomogram Model to Identify Atherosclerotic Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Sun, Huiwen
    Men, Chen
    Deng, Hui
    Wang, Chun
    Li, Ruiyao
    Sun, Yale
    Yang, Hao
    Wu, Mingyang
    Zheng, Wen
    Zhan, Yiyang
    DISCOVERY MEDICINE, 2023, 35 (179) : 1114 - 1122
  • [16] Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis
    Iglay, Kristy
    Hannachi, Hakima
    Engel, Samuel S.
    Li, Xueying
    O'Connell, David
    Moore, Lori M.
    Rajpathak, Swapnil
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (05) : 743 - 751
  • [17] Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular risk
    Targher, Giovanni
    Byrne, Christopher D.
    EUROPEAN HEART JOURNAL, 2020, 41 (02) : 331 - 331
  • [18] Relationship between atherosclerotic cardiovascular disease and diabetic retinopathy in patients with type 2 diabetes mellitus
    Li, Li
    Gao, Jiyun
    Rao, Xiaopang
    Liu, Xiaoling
    MEDICINE, 2024, 103 (19) : E38051
  • [19] PROSPECTIVE-STUDY OF LIPOPROTEIN(A) AS A RISK FACTOR FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE IN PATIENTS WITH DIABETES
    HIRAGA, T
    KOBAYASHI, T
    OKUBO, M
    NAKANISHI, K
    SUGIMOTO, T
    OHASHI, Y
    MURASE, T
    DIABETES CARE, 1995, 18 (02) : 241 - 244
  • [20] Cardiovascular disease in patients with type 2 diabetes
    Jeon, Ja Young
    Kim, Dae Jung
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (04) : 614 - 616
12345